These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Lack of a specific effect of corticotropin-releasing hormone (CRH) on plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in normal subjects.
    Author: Zacharieva S, Muchá I, Wippermann M, Sheitanova S, Andonova K.
    Journal: Prostaglandins Leukot Essent Fatty Acids; 1995 Jan; 52(1):55-7. PubMed ID: 7708821.
    Abstract:
    The responses of plasma adrenocorticotrophic hormone (corticotrophin, ACTH), cortisol and 13,14-dihydro-15-keto-prostaglandin E2 (PGE2-M), a stable metabolite of prostaglandin E2 (PGE2) to i.v. injection of corticotrophin-releasing hormone (CRH) were studied in eight healthy subjects before and after a dexamethasone suppression test. We demonstrated a slight increase in PGE2-M after CRH injection in a dose that markedly augmented ACTH and cortisol levels. CRH did not produce any significant changes in ACTH, cortisol or PGE2-M after dexamethasone treatment. The results did not confirm a specific effect of CRH on PGE2 production.
    [Abstract] [Full Text] [Related] [New Search]